SCHEMBL30367241

SCHEMBL30367241

CC(C)C(=O)N1CC=C(c2cc(-c3ccc(N)cc3)n3c(N)nnc3c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 11/20 0.43
QDPR P09417 2/20 0.39
CCR1 P32246 1/20 0.36
KCNH2 Q12809 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
MAPT P10636 1/20 0.34
CDK7 P50613 2/20 0.33
CDK13 Q14004 2/20 0.33
CDK12 Q9NYV4 2/20 0.33
KDR P35968 1/20 0.33
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30367515 0.84 NAMPT (0.41) NAMPTQDPRCCR1KCNH2HRH3
SCHEMBL30367031 0.72 NAMPT (0.43) NAMPTQDPRCCR1KCNH2HRH3
SCHEMBL30367298 0.71 NAMPT (0.48) NAMPTQDPRCCR1KCNH2HRH3
SCHEMBL30367405 0.70 NAMPT (0.41) NAMPTQDPRCCR1KCNH2HRH3
SCHEMBL14197130 0.70 NAMPT (0.58) NAMPTQDPRCCR1KCNH2HRH3
SCHEMBL14320389 0.68 QDPR (0.67) NAMPTQDPRKCNH2HRH3MAPT
SCHEMBL27694889 0.67 NAMPT (0.55) NAMPTQDPRCCR1KCNH2HRH3
SCHEMBL27762102 0.67 ALDH1A1 (0.50) NAMPTQDPRCCR1KCNH2HRH3
SCHEMBL30367208 0.65 TNK2 (0.60) NAMPT
SCHEMBL29921781 0.65 KDR (0.46) QDPRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023155886-A1 PYRAZOLOPYRIDINE COMPOUNDS AS TAM INHIBITORS SHANGHAI ANTENGENE CORPORATION LIMITED (CN) 2023-08-24 WO disclosed
CN-116437918-A Pyrazolopyridine compounds as TAM inhibitors 上海德琪医药科技有限公司 2023-07-14 CN disclosed
WO-2023051464-A1 PYRAZOLOPYRIDINE COMPOUNDS AS TAM INHIBITORS SHANGHAI ANTENGENE CORPORATION LIMITED (CN) 2023-04-06 WO disclosed